OraSure Technologies | OSUR - 现金及等价物



金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 218.4M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


现金及等价物 更改 日
Agilent USD 1.76B 31M 2025-12
AngioDynamics USD 41.64M 14.26M 2025-09
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Cerus USD 15.67M 321K 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 326M 37M 2025-12
Dexcom USD 917.7M 918M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Illumina USD 1.42B 368M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Mesa Laboratories USD 28.98M 8.55M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
OraSure Technologies USD 199.28M 17.2M 2025-12
Quidel USD 169.8M 71.7M 2025-12
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
STAAR Surgical USD 153.15M 23M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Trinity Biotech USD 1.34M 3.83M 2025-09
Waters USD 587.83M 128.71M 2025-12